(ALAB) Astera Labs, Common Stock - Ratings and Ratios
Connectivity Solutions, Integrated Circuits, Modules, Boards, Software Suite
ALAB EPS (Earnings per Share)
ALAB Revenue
Description: ALAB Astera Labs, Common Stock
Astera Labs, Inc. is a semiconductor company specializing in connectivity solutions for cloud and AI infrastructure, offering a range of products including high-speed connectivity integrated circuits, modules, and software. Their COSMOS software suite is a key differentiator, enabling management and optimization of resources for large-scale cloud infrastructure.
To evaluate the companys performance, we can look at key performance indicators (KPIs) such as revenue growth, gross margin, and operating expenses as a percentage of revenue. Astera Labs ability to expand its customer base, including hyperscalers and system original equipment manufacturers, is crucial. The companys product diversification, including AI Servers and Clustering, General Purpose Servers, and Networking solutions, is a positive factor. We can also analyze the companys competitive position in the semiconductor industry, its research and development (R&D) investments, and its ability to innovate and stay ahead of competitors.
From a financial perspective, Astera Labs market capitalization is approximately $14.9 billion, with a P/E ratio of 68.95, indicating a relatively high valuation. The companys return on equity (RoE) is 4.43%, which may be considered low. To further assess the companys financial health, we can examine its cash flow generation, debt-to-equity ratio, and interest coverage ratio. These metrics will provide insights into Astera Labs ability to invest in growth initiatives, manage its debt, and weather potential economic downturns.
To make informed investment decisions, we need to monitor Astera Labs progress in executing its business strategy, its ability to maintain a competitive edge, and its financial performance. By analyzing these factors, we can better understand the companys potential for long-term growth and its attractiveness as an investment opportunity.
ALAB Stock Overview
| Market Cap in USD | 38,712m |
| Sub-Industry | Semiconductors |
| IPO / Inception | 2024-03-20 |
ALAB Stock Ratings
| Growth Rating | 75.6% |
| Fundamental | 86.8% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 354% |
| Analyst Rating | 4.47 of 5 |
ALAB Dividends
Currently no dividends paidALAB Growth Ratios
| Growth Correlation 3m | 93.5% |
| Growth Correlation 12m | 45.3% |
| Growth Correlation 5y | 60% |
| CAGR 5y | 262.15% |
| CAGR/Max DD 3y | 4.12 |
| CAGR/Mean DD 3y | 8.71 |
| Sharpe Ratio 12m | 1.04 |
| Alpha | 0.00 |
| Beta | 0.895 |
| Volatility | 84.77% |
| Current Volume | 5925.3k |
| Average Volume 20d | 4669.7k |
| Stop Loss | 236 (-5.4%) |
| Signal | 1.32 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (100.2m TTM) > 0 and > 6% of Revenue (6% = 36.3m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 11.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 177.4% (prev 360.3%; Δ -182.9pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 249.1m > Net Income 100.2m (YES >=105%, WARN >=100%) |
| Net Debt (-131.1m) to EBITDA (46.6m) ratio: -2.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 11.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (178.1m) change vs 12m ago 14.76% (target <= -2.0% for YES) |
| Gross Margin 75.52% (prev 77.33%; Δ -1.81pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 55.38% (prev 25.07%; Δ 30.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 4.53
| (A) 0.85 = (Total Current Assets 1.18b - Total Current Liabilities 106.4m) / Total Assets 1.27b |
| (B) -0.10 = Retained Earnings (Balance) -125.8m / Total Assets 1.27b |
| (C) 0.04 = EBIT TTM 42.3m / Avg Total Assets 1.09b |
| (D) -0.91 = Book Value of Equity -122.9m / Total Liabilities 135.7m |
| Total Rating: 4.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.77
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 0.56% = 0.28 |
| 3. FCF Margin 34.74% = 7.50 |
| 4. Debt/Equity 0.03 = 2.50 |
| 5. Debt/Ebitda 0.73 = 2.10 |
| 6. ROIC - WACC (= 46.67)% = 12.50 |
| 7. RoE 9.94% = 0.83 |
| 8. Rev. Trend 92.95% = 6.97 |
| 9. EPS Trend 81.77% = 4.09 |
What is the price of ALAB shares?
Over the past week, the price has changed by +8.25%, over one month by +33.77%, over three months by +168.41% and over the past year by +438.27%.
Is Astera Labs, Common Stock a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALAB is around 248.18 USD . This means that ALAB is currently overvalued and has a potential downside of -0.48%.
Is ALAB a buy, sell or hold?
- Strong Buy: 9
- Buy: 7
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ALAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 175.4 | -29.6% |
| Analysts Target Price | 175.4 | -29.6% |
| ValueRay Target Price | 278.7 | 11.8% |
Last update: 2025-09-13 05:00
ALAB Fundamental Data Overview
CCE Cash And Equivalents = 1.07b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 294.8101
P/E Forward = 119.0476
P/S = 63.9294
P/B = 34.0864
Beta = None
Revenue TTM = 605.5m USD
EBIT TTM = 42.3m USD
EBITDA TTM = 46.6m USD
Long Term Debt = 29.3m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 4.67m USD (from shortTermDebt, last quarter)
Debt = 34.0m USD (Calculated: Short Term 4.67m + Long Term 29.3m)
Net Debt = -131.1m USD (from netDebt column, last quarter)
Enterprise Value = 37.68b USD (38.71b + Debt 34.0m - CCE 1.07b)
Interest Coverage Ratio = unknown (Ebit TTM 42.3m / Interest Expense TTM 0.0)
FCF Yield = 0.56% (FCF TTM 210.4m / Enterprise Value 37.68b)
FCF Margin = 34.74% (FCF TTM 210.4m / Revenue TTM 605.5m)
Net Margin = 16.54% (Net Income TTM 100.2m / Revenue TTM 605.5m)
Gross Margin = 75.52% ((Revenue TTM 605.5m - Cost of Revenue TTM 148.2m) / Revenue TTM)
Tobins Q-Ratio = -306.7 (set to none) (Enterprise Value 37.68b / Book Value Of Equity -122.9m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 34.0m)
Taxrate = -1.11% (set to none) (-560.0k / 50.7m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 11.10 (Total Current Assets 1.18b / Total Current Liabilities 106.4m)
Debt / Equity = 0.03 (Debt 34.0m / last Quarter total Stockholder Equity 1.14b)
Debt / EBITDA = 0.73 (Net Debt -131.1m / EBITDA 46.6m)
Debt / FCF = 0.16 (Debt 34.0m / FCF TTM 210.4m)
Total Stockholder Equity = 1.01b (last 4 quarters mean)
RoA = 7.88% (Net Income 100.2m, Total Assets 1.27b )
RoE = 9.94% (Net Income TTM 100.2m / Total Stockholder Equity 1.01b)
RoCE = 4.08% (Ebit 42.3m / (Equity 1.01b + L.T.Debt 29.3m))
RoIC = 46.67% (Ebit 42.3m / (Assets 1.27b - Current Assets 1.18b))
WACC = unknown (E(38.71b)/V(38.75b) * Re(9.32%)) + (D(34.0m)/V(38.75b) * Rd(0.0%) * (1-Tc(none)))
Shares Correlation 3-Years: 95.40 | Cagr: 16.19%
Discount Rate = 9.32% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 64.90% ; FCFE base≈143.7m ; Y1≈94.3m ; Y5≈43.1m
Fair Price DCF = 4.17 (DCF Value 693.9m / Shares Outstanding 166.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 81.77 | EPS CAGR: 137.8% | SUE: 1.86 | # QB: 1
Revenue Correlation: 92.95 | Revenue CAGR: 115.9% | SUE: N/A | # QB: None
Additional Sources for ALAB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle